News

FDA Issues Risk Warning for Aldi Churro Recall in 13 States
Camerican International, Inc. issued a voluntary recall of Casa Mamita Churro Bites due to a potential undeclared allergen.
FDA vaccine chief leaving agency after less than 3 months
Dr. Vinay Prasad is stepping down as the Food and Drug Administration's top vaccine regulator after a brief tenure.
Fierce Pharma1h
Vinay Prasad's exit signals FDA's probable slip toward more permissive regulation of cell and gene therapy: analyst
But this time, the unknown is hitting the industry in a different way from when Prasad was tapped to lead CBER less than ...
Top FDA vaccine regulator abruptly exits post
DIRECTING A CHANGING CDC — The Senate voted to confirm Susan Monarez as the next CDC director Tuesday, marking an end to the ...
The American Journal of Managed Care43m
FDA Recommends Sarepta Resume DMD Gene Therapy Shipments for Ambulatory Patients
Shipment of delandistrogene moxeparvovec, a gene therapy for Duchenne muscular dystrophy (DMD), will resume following a ...
Why the FDA wants to restrict kratom-related products
The FDA announced that it is urging the Drug Enforcement Agency to "classify 7-OH as a Schedule 1 substance, placing it on a ...
Fierce Pharma21h
FDA taps newly appointed George Tidmarsh as acting CBER leader after Vinay Prasad exit
Freshly appointed Center for Drug Evaluation and Research (CDER) leader George Tidmarsh M.D., Ph.D., will now take on the role of acting director of CBER as well, according to an internal letter from ...
Phoenix New Times54m
FDA recommends ban of potent 7-OH kratom variant
The synthetic variant is legal and has opioid-like effects. One official called it “a recipe for a public safety disaster.” ...